适应性地利用多个现实世界的数据来源,以基于相似性的治疗效果估计
Meihua Long1, Jiali Song1, Zhiwei Rong1
1Department of Biostatistics, Peking University, Beijing, China.
Journal of biopharmaceutical statistics
|April 1, 2024
概括
这项研究介绍了基于树的蒙特卡罗 (TMC),这是一种在临床试验中整合真实世界数据 (RWD) 的新方法. TMC根据临床试验数据的相似性对RWD源进行动态权重,提高治疗效果估计的准确性.
科学领域:
- 生物统计学 生物统计学
- 临床试验方法论 临床试验方法论
- 现实世界的证据 (RWE)
背景情况:
- 在医疗产品开发和评估中,现实世界数据 (RWD) 的使用越来越多.
- 缺乏标准化方法来量化来自外部RWD来源的信息.
- 需要强大的方法来将各种RWD整合到临床试验分析中.
研究的目的:
- 提出和评估一种新的研究设计方法,即基于树的蒙特卡罗 (TMC).
- 根据临床试验数据的相似性,动态整合来自各种RWD来源的患者.
- 通过适当加权RWD,提高治疗效果计算的准确性.
主要方法:
- 开发一种倾向评分来衡量临床试验数据与RWD之间的相似性.
- 建立基于相似度指标的层次聚类树,以组合RWD源.
- 在集群框架内应用高斯过程方法来合成治疗效应.
主要成果:
- 拟议的集群树有效地识别和量化RWD来源和临床试验数据之间的相似性.
- 具有较高相似性的数据源在治疗效果估计中获得了更大的权重.
- 与元分析预测先验 (MAP) 方法相比,TMC方法显示了偏差减少和更接近真实值的估计.
结论:
- 基于树的蒙特卡罗 (TMC) 提供了一个强大的和可适应的框架,用于在临床研究中整合RWD.
- 基于数据相似性的权重机制提高了治疗效果估计的可靠性.
- TMC为利用RWD在医疗产品评估中的现有方法提供了一个统计学上合理的替代方案.
更多相关视频
相关概念视频
Regression Toward the Mean
6.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
Analysis of Population Pharmacokinetic Data
254
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
254
Comparing the Survival Analysis of Two or More Groups
181
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
181
Strategies for Assessing and Addressing Confounding
99
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
99
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
69
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
69


